Federated Hermes’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.62M | Buy |
703,006
+698,253
| +14,691% | +$6.26M | 0.01% | 791 |
|
|
2026
Q1 | $38.7K | Buy |
4,753
+1,660
| +54% | +$15K | ﹤0.01% | 1707 |
|
|
2025
Q4 | $20.8K | Buy |
3,093
+2,401
| +347% | +$18.1K | ﹤0.01% | 1760 |
|
|
2025
Q3 | $6K | Buy |
+692
| New | +$5.39K | ﹤0.01% | 1925 |
|
|
2025
Q2 | – | Sell |
-56,124
| Closed | -$360K | – | 2152 |
|
|
2025
Q1 | $360K | Buy |
56,124
+5,618
| +11% | +$46.4K | ﹤0.01% | 1392 |
|
|
2024
Q4 | $406K | Buy |
50,506
+2,124
| +4% | +$20.5K | ﹤0.01% | 1364 |
|
|
2024
Q3 | $611K | Sell |
48,382
-1,046
| -2% | -$13.5K | ﹤0.01% | 1284 |
|
|
2024
Q2 | $626K | Buy |
49,428
+4,045
| +9% | +$40.7K | ﹤0.01% | 1256 |
|
|
2024
Q1 | $217K | Sell |
45,383
-7,330
| -14% | -$34K | ﹤0.01% | 1480 |
|
|
2023
Q4 | $253K | Sell |
52,713
-409,114
| -89% | -$2.5M | ﹤0.01% | 1478 |
|
|
2023
Q3 | $3.34M | Buy |
461,827
+240,514
| +109% | +$1.92M | 0.01% | 795 |
|
|
2023
Q2 | $1.64M | Buy |
221,313
+141,640
| +178% | +$1.11M | ﹤0.01% | 1019 |
|
|
2023
Q1 | $552K | Buy |
79,673
+60,224
| +310% | +$554K | ﹤0.01% | 1377 |
|
|
2022
Q4 | $200K | Buy |
19,449
+15,183
| +356% | +$268K | ﹤0.01% | 1557 |
|
|
2022
Q3 | $78K | Sell |
4,266
-1,446
| -25% | -$62.7K | ﹤0.01% | 1629 |
|
|
2022
Q2 | $294K | Sell |
5,712
-26,677
| -82% | -$1.38M | ﹤0.01% | 1471 |
|
|
2022
Q1 | $2.38M | Buy |
+32,389
| New | +$2.89M | 0.01% | 992 |
|
|
2021
Q2 | – | Sell |
-3,461
| Closed | -$628K | – | 2290 |
|
|
2021
Q1 | $628K | Buy |
+3,461
| New | +$690K | ﹤0.01% | 1515 |
|
|
2020
Q4 | – | Sell |
-23,519
| Closed | -$2.55M | – | 2296 |
|
|
2020
Q3 | $2.55M | Sell |
23,519
-52,860
| -69% | -$6.44M | 0.01% | 904 |
|
|
2020
Q2 | $6.37M | Buy |
76,379
+47,859
| +168% | +$1.83M | 0.02% | 646 |
|
|
2020
Q1 | $387K | Sell |
28,520
-27,316
| -49% | -$231K | ﹤0.01% | 1447 |
|
|
2019
Q4 | $222K | Buy |
55,836
+40,052
| +254% | +$174K | ﹤0.01% | 1588 |
|
|
2019
Q3 | $79K | Buy |
15,784
+1,254
| +9% | +$6.86K | ﹤0.01% | 1678 |
|
|
2019
Q2 | $85K | Buy |
14,530
+633
| +5% | +$4.98K | ﹤0.01% | 1628 |
|
|
2019
Q1 | $153K | Sell |
13,897
-351
| -2% | -$11.1K | ﹤0.01% | 1575 |
|
|
2018
Q4 | $524K | Sell |
14,248
-2,545
| -15% | -$98.6K | ﹤0.01% | 1429 |
|
|
2018
Q3 | $631K | Buy |
16,793
+221
| +1% | +$6.22K | ﹤0.01% | 1448 |
|
|
2018
Q2 | $444K | Sell |
16,572
-290
| -2% | -$9.8K | ﹤0.01% | 1433 |
|
|
2018
Q1 | $708K | Sell |
16,862
-10,782
| -39% | -$433K | ﹤0.01% | 1318 |
|
|
2017
Q4 | $686K | Sell |
27,644
-1,946
| -7% | -$47.5K | ﹤0.01% | 1315 |
|
|
2017
Q3 | $675K | Buy |
29,590
+19,511
| +194% | +$437K | ﹤0.01% | 1293 |
|
|
2017
Q2 | $232K | Buy |
+10,079
| New | +$198K | ﹤0.01% | 1513 |
|
Other funds holding NVAX
SCM
S
Federated Hermes's NVAX Position: Q2 2026 in Review
Federated Hermes increased its Novavax (NVAX) stake by 14,691% in Q2 2026, buying an estimated $6.26M and bringing the position to 703,006 shares worth $6.62M. The position accounts for 0.01% of the portfolio, ranked #791.
Federated Hermes first reported a position in NVAX in Q2 2017 and has held it in 32 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Federated Hermes held 703,006 shares of Novavax worth $6.62M as of Q2 2026.
- Federated Hermes bought 698,253 Novavax shares in Q2 2026, an estimated $6.26M.
- Novavax made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #791 holding.
- Federated Hermes first reported a position in Novavax in Q2 2017 and has held it in 32 quarters since.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.